National Doctors' Day is being celebrated across India today to honor the dedication and service of doctors who work day and night to save lives.
New hormone plant has become the latest milestone for Corona Remedies as the company strengthens its position in women's healthcare with the commercial launch of a dedicated hormone manufacturing facility in Bhayla, Ahmedabad.
A monthly recap on major events in indian pharmacuetical industry, which saw numerous policy reforms, innovation, drug approvals, and disease control methods
India has earned global recognition for its India pharma industry, but the next phase of growth could depend on a major shift.
Aurobindo Pharma's Lannett Acquisition has officially entered a new phase with the successful completion of its USD 250 million buyout of US-based Lannett Company.
Aarogya Setu 2.0 is no longer just a COVID-19 app. The Centre has launched a revamped version of the platform with several new features that bring PM-JAY Wallet, Digital Health Records, and other healthcare services under one roof.
The Union Ministry of Health and Family Welfare has announced a single platform for all medicine-related information, which creates a space that users can easily access for domestic generic medicines through the respective generic name and brand name
The Ebola crisis in DR Congo has entered a more dangerous phase, with the Ebola outbreak now spreading to a fourth province.
India's Pharma Exports are entering a new phase as drugmakers expand beyond their biggest market, the US, to tap fresh opportunities in Brazil.
Alembic marks another milestone in securing approval from the USFDA for Dapsone Gel, which is a treatment for acne vulgaris, a skin disorder. Alembic marks this as an achievement, which turns them on to the US market